[Form 4] The Chemours Company Insider Trading Activity
The Chemours Company (CC) reporting person Will David, identified as the company's Chief Accounting Officer, reported a routine tax-withholding transaction tied to vested restricted stock units and dividend equivalent units. On 08/12/2025 2,374 shares were withheld at a price of $12.42 to satisfy tax obligations; no shares were sold and the transaction is exempt under Rule 16b-3. After the withholding, Mr. David beneficially owns 25,189.8011 shares (direct ownership). The filing includes a Power of Attorney as Exhibit 24 and was signed by an attorney-in-fact on 08/14/2025.
The Chemours Company (CC), tramite la persona che effettua la comunicazione Will David, identificato come Chief Accounting Officer della società, ha segnalato un'operazione ordinaria di ritenuta fiscale collegata a restricted stock units maturate e dividend equivalent units. In data 08/12/2025 sono state trattenute 2,374 azioni al prezzo di $12.42 per soddisfare le obbligazioni fiscali; non sono state vendute azioni e l'operazione è esente ai sensi della Rule 16b-3. Dopo la ritenuta, il sig. David detiene di fatto 25,189.8011 azioni (proprietà diretta). Il deposito include una Procura come Exhibit 24 ed è stato firmato da un mandatario il 08/14/2025.
The Chemours Company (CC), con la persona informante Will David, identificado como Chief Accounting Officer de la compañía, informó una retención fiscal rutinaria relacionada con unidades de acciones restringidas adquiridas y unidades equivalentes de dividendos. El 08/12/2025 se retuvieron 2,374 acciones a un precio de $12.42 para cubrir obligaciones fiscales; no se vendieron acciones y la operación está exenta conforme a la Rule 16b-3. Tras la retención, el Sr. David posee beneficiariamente 25,189.8011 acciones (propiedad directa). La presentación incluye un Poder como Exhibit 24 y fue firmada por un apoderado el 08/14/2025.
The Chemours Company (CC)의 보고 담당자 Will David는 회사의 Chief Accounting Officer로서 확정된 제한주식단위 및 배당 등가단위와 관련된 일상적인 세금 원천징수 거래를 보고했습니다. 08/12/2025에 세금 납부를 위해 2,374주가 주당 $12.42에 원천징수되었으며, 주식 매각은 없었고 해당 거래는 Rule 16b-3에 따라 면제됩니다. 원천징수 후 David 씨는 실질적으로 25,189.8011주를 보유하고 있습니다(직접 소유). 제출서류에는 Exhibit 24로 위임장이 포함되어 있으며 08/14/2025에 대리인이 서명했습니다.
The Chemours Company (CC), personne déclarante Will David, identifié comme Chief Accounting Officer de la société, a signalé une opération courante de retenue fiscale liée à des restricted stock units acquises et des dividend equivalent units. Le 08/12/2025, 2,374 actions ont été retenues au prix de $12.42 pour s'acquitter des obligations fiscales ; aucune action n'a été vendue et la transaction est exonérée en vertu de la Rule 16b-3. Après la retenue, M. David détient effectivement 25,189.8011 actions (propriété directe). Le dépôt comprend une procuration en tant qu'Exhibit 24 et a été signé par un mandataire le 08/14/2025.
The Chemours Company (CC), meldende Person Will David, ausgewiesen als Chief Accounting Officer des Unternehmens, berichtete über eine routinemäßige steuerliche Einbehaltung im Zusammenhang mit ausgeübten Restricted Stock Units und Dividend Equivalent Units. Am 08/12/2025 wurden 2,374 Aktien zum Preis von $12.42 einbehalten, um Steuerpflichten zu erfüllen; es wurden keine Aktien verkauft und die Transaktion ist gemäß Rule 16b-3 ausgenommen. Nach der Einbehaltung besitzt Herr David wirtschaftlich 25,189.8011 Aktien (Direktbesitz). Die Einreichung enthält eine Vollmacht als Exhibit 24 und wurde am 08/14/2025 von einem Bevollmächtigten unterschrieben.
- Proper disclosure of the withholding transaction with transaction code F and explanatory remarks
- Transaction exempt under Rule 16b-3, indicating it was an administrative tax-withholding on vested awards rather than an open-market sale
- Power of Attorney attached as Exhibit 24 and form signed by attorney-in-fact, showing filing formalities were followed
- None.
Insights
TL;DR: Routine tax-withholding on vested equity; minor change in reported holdings, no sales, no unusual trading activity.
The Form 4 discloses an internal tax-related withholding of 2,374 shares tied to vested restricted stock units and dividend equivalents at $12.42 per share. Such transactions are typically administrative and exempt under Rule 16b-3, indicating these were not discretionary open-market sales. The post-transaction beneficial ownership is 25,189.8011 shares direct, which is a small-scale holding change for an officer and unlikely to affect company control or signal a material change in insider sentiment.
TL;DR: Filing reflects routine equity compensation mechanics with appropriate disclosures and Power of Attorney attached.
The report properly identifies the reporting person and relationship (Chief Accounting Officer), lists the withholding as transaction code F with explanatory remarks, and cites Rule 16b-3 exemption. The presence of a Power of Attorney exhibit and attorney-in-fact signature indicates compliance with filing formalities. There are no disclosures of derivative exercises, open-market transactions, or departures that would raise governance concerns.
The Chemours Company (CC), tramite la persona che effettua la comunicazione Will David, identificato come Chief Accounting Officer della società, ha segnalato un'operazione ordinaria di ritenuta fiscale collegata a restricted stock units maturate e dividend equivalent units. In data 08/12/2025 sono state trattenute 2,374 azioni al prezzo di $12.42 per soddisfare le obbligazioni fiscali; non sono state vendute azioni e l'operazione è esente ai sensi della Rule 16b-3. Dopo la ritenuta, il sig. David detiene di fatto 25,189.8011 azioni (proprietà diretta). Il deposito include una Procura come Exhibit 24 ed è stato firmato da un mandatario il 08/14/2025.
The Chemours Company (CC), con la persona informante Will David, identificado como Chief Accounting Officer de la compañía, informó una retención fiscal rutinaria relacionada con unidades de acciones restringidas adquiridas y unidades equivalentes de dividendos. El 08/12/2025 se retuvieron 2,374 acciones a un precio de $12.42 para cubrir obligaciones fiscales; no se vendieron acciones y la operación está exenta conforme a la Rule 16b-3. Tras la retención, el Sr. David posee beneficiariamente 25,189.8011 acciones (propiedad directa). La presentación incluye un Poder como Exhibit 24 y fue firmada por un apoderado el 08/14/2025.
The Chemours Company (CC)의 보고 담당자 Will David는 회사의 Chief Accounting Officer로서 확정된 제한주식단위 및 배당 등가단위와 관련된 일상적인 세금 원천징수 거래를 보고했습니다. 08/12/2025에 세금 납부를 위해 2,374주가 주당 $12.42에 원천징수되었으며, 주식 매각은 없었고 해당 거래는 Rule 16b-3에 따라 면제됩니다. 원천징수 후 David 씨는 실질적으로 25,189.8011주를 보유하고 있습니다(직접 소유). 제출서류에는 Exhibit 24로 위임장이 포함되어 있으며 08/14/2025에 대리인이 서명했습니다.
The Chemours Company (CC), personne déclarante Will David, identifié comme Chief Accounting Officer de la société, a signalé une opération courante de retenue fiscale liée à des restricted stock units acquises et des dividend equivalent units. Le 08/12/2025, 2,374 actions ont été retenues au prix de $12.42 pour s'acquitter des obligations fiscales ; aucune action n'a été vendue et la transaction est exonérée en vertu de la Rule 16b-3. Après la retenue, M. David détient effectivement 25,189.8011 actions (propriété directe). Le dépôt comprend une procuration en tant qu'Exhibit 24 et a été signé par un mandataire le 08/14/2025.
The Chemours Company (CC), meldende Person Will David, ausgewiesen als Chief Accounting Officer des Unternehmens, berichtete über eine routinemäßige steuerliche Einbehaltung im Zusammenhang mit ausgeübten Restricted Stock Units und Dividend Equivalent Units. Am 08/12/2025 wurden 2,374 Aktien zum Preis von $12.42 einbehalten, um Steuerpflichten zu erfüllen; es wurden keine Aktien verkauft und die Transaktion ist gemäß Rule 16b-3 ausgenommen. Nach der Einbehaltung besitzt Herr David wirtschaftlich 25,189.8011 Aktien (Direktbesitz). Die Einreichung enthält eine Vollmacht als Exhibit 24 und wurde am 08/14/2025 von einem Bevollmächtigten unterschrieben.
FAQ
What did Will David report on the Form 4 for Chemours (CC)?
Did the Form 4 report any open-market sales by the reporting person?
What is the reporting person's relationship to Chemours (CC)?
How many shares does Will David beneficially own after the transaction?
Is this transaction considered a Section 16(b) short-swing transaction?
